Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy save search
Kiromic BioPharma Achieves Milestone with Timely Completion of Expanded cGMP Manufacturing Facility to Support Cell Therapy Oncology Pipeline
Published: 2022-07-07 (Crawled : 21:00) - biospace.com/
KRBP | $2.3 -90.21% 15K
|
Health Technology
|
| O: 3394.76%
H: 70.79%
C: 23.15%
biopharma therapy milestone
BioCardia Announces FDA Approval of CardiAMP Heart Failure II Protocol for Autologous Cell Therapy for Ischemic Heart Failure
Published: 2023-11-14 (Crawled : 12:00) - globenewswire.com
BCDA | $0.363 -1.39% -1.4% 62K
|
Health Technology
|
| O: 223.31%
H: 20.16%
C: -17.05%
fda approval cell cardiamp heart therapy
Genprex Expands Gene Therapy Oncology Pipeline to Include Small Cell Lung Cancer
Published: 2022-01-04 (Crawled : 16:00) - biospace.com/
GNPX | $2.16 -2.26% -2.31% 17K
|
Health Technology
|
| O: 103.92%
H: 0.0%
C: 0.0%
gene therapy cel lung cancer therapy cancer
Hoth Therapeutics Announces FDA Acceptance of IND Application for HT-001 for the Treatment of Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy
Published: 2022-12-29 (Crawled : 14:00) - prnewswire.com
HOTH | $1.23 0.0% 20K
|
Health Technology
|
| O: 102.05%
H: 40.61%
C: 20.58%
ht-001 treatment fda application therapeutics therapy cancer growth
ThermoGenesis Announces Roll Out of ReadyStart cGMP Suites for Early-Stage Cell and Gene Therapy Companies
Published: 2023-03-15 (Crawled : 13:00) - thermogenesis.com
THMO | $0.613 -2.7% -2.77% 21K
|
Health Technology
|
| O: 98.1%
H: 26.07%
C: 0.24%
companies therapy
PolarityTE Announces FDA Regenerative Medicine Advanced Therapy Designation Granted to SkinTE®
Published: 2022-05-13 (Crawled : 12:20) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 92.39%
H: 0.0%
C: 0.0%
skinte fda designation granted therapy grant
AVROBIO Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5 Million
Published: 2023-05-22 (Crawled : 12:00) - biospace.com/
AVRO | $1.23 0.82% 0.81% 37K
|
Health Technology
|
| O: 83.2%
H: 19.72%
C: -7.75%
program agreement therapy
Marker Therapeutics Announces FDA Clearance of IND for MT-601, the six-antigen targeted T Cell Therapy for the treatment of relapsed/refractory Non-Hodgkin Lymphoma
Published: 2022-08-04 (Crawled : 21:00) - globenewswire.com
MRKR | $4.24 -1.62% -1.65% 13K
|
Consumer Services
|
| O: 81.82%
H: 10.0%
C: -10.0%
mt-601 treatment fda clearance therapeutics therapy
NexImmune Announces Data Showing AIM ACT T cells Enhance the Response to Bispecific T cell Engager Therapy at the 2023 Tandem Meetings: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR
Published: 2023-02-16 (Crawled : 14:00) - globenewswire.com
NEXI | $3.15 -11.94% 6.9K
|
|
| O: 78.05%
H: 11.51%
C: -17.79%
cibmtr response therapy
Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs
Published: 2023-08-09 (Crawled : 12:00) - globenewswire.com
PPRUF | News | $361.9 37.56% 4.3K
|
Consumer Non-Durables
|
| O: 1.36%
H: 3.13%
C: 2.6%
PPRUY | News | $36.03 -0.11% 330K
|
Manufacturing
|
| O: 0.62%
H: 0.32%
C: -0.47%
DBTX | $4.91 -0.81% -0.2% 0
|
Health Technology
|
| O: 74.36%
H: 0.0%
C: 0.0%
REGN | $893.66 -0.84% -0.84% 450K
|
Health Technology
|
| O: 1.9%
H: 0.0%
C: 0.0%
acquire therapy
Important Milestone Reached for Evaxion Biotech’s EVX-01 Personalized Cancer Therapy
Published: 2022-09-21 (Crawled : 10:00) - globenewswire.com
EVAX | $4.21 2.43% 2.38% 35K
|
Manufacturing
|
| O: 71.05%
H: 8.3%
C: -28.31%
evx-01 therapy cancer milestone
Presentation During New Advances in the Management of Pancreatic Cancer Course Highlights Intra-Arterial Chemotherapy as a Potential Innovative Treatment for Pancreatic Cancer
Published: 2021-11-09 (Crawled : 12:26) - renovorx.com
RNXT | $1.19 5.07% 5.3K
|
|
| O: 67.28%
H: 38.23%
C: -9.83%
presentation treatment potential therapy cancer pancreatic pancreas
Voyager Therapeutics Announces License Option Agreement with Pfizer for Next-Generation TRACERᵀᴹ AAV Capsids to Enable Neurologic and Cardiovascular Gene Therapy Programs
Published: 2021-10-06 (Crawled : 12:00) - biospace.com/
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -0.61%
H: 0.33%
C: -0.1%
VYGR | $7.55 -2.46% -2.52% 1M
|
Health Technology
|
| O: 61.54%
H: 3.26%
C: -3.01%
cardiovascular gene therapy therapy license cardio aav9 gene therapies aav capsids
Edesa Biotech to Study Its Investigational Drug as Potential Rescue Therapy
Published: 2021-01-26 (Crawled : 13:00) - biospace.com/
EDSA | $4.4 -2.3% 1.4K
|
Health Technology
|
| O: 61.3%
H: 2.02%
C: -16.14%
therapy biotech drug potential
RAPT Therapeutics Reports Positive Topline Results from Phase 1b Trial of RPT193 Monotherapy in Atopic Dermatitis
Published: 2021-06-14 (Crawled : 18:00) - biospace.com/
RAPT | $7.94 -1.24% -1.26% 710K
|
Health Technology
|
| O: 56.92%
H: 44.1%
C: 37.34%
phase 1 positive therapy results dermatitis topline trial atopic dermatitis phase 1b phase 2b
Timber Pharmaceuticals Receives FDA Breakthrough Therapy Designation for TMB-001 for the Treatment of Congenital Ichthyosis
Published: 2022-05-31 (Crawled : 17:00) - biospace.com/
TMBR | $0.3426 -2.69% 3K
|
Health Technology
|
| O: 56.35%
H: 2.83%
C: -26.01%
tmb-001 treatment fda designation therapy
Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseases
Published: 2023-12-26 (Crawled : 07:00) - globenewswire.com
GRCL | $10.25 -0.29% 6.4M
|
Manufacturing
|
| O: 54.84%
H: 0.0%
C: 0.0%
biotechnologies cell acquired therapy
Altamira Therapeutic's SemaPhore Platform Shown Particularly Effective in Intracellular mRNA Delivery for Cancer Therapy
Published: 2022-07-19 (Crawled : 13:00) - globenewswire.com
CYTO | $1.48 -7.95% 25K
|
Manufacturing
|
| O: 49.12%
H: 10.29%
C: -21.47%
mrna therapy cancer platform
Lysogene to Provide Updates and Topline Results from Phase 2/3 AAVance Gene Therapy Clinical Study and Host Webcast on Wednesday, November 23, 2022 Regulatory News: Lysogene announced that it will host...
Published: 2022-11-18 (Crawled : 09:00) - biospace.com/
RAPT | $7.94 -1.24% -1.26% 710K
|
Health Technology
|
| O: -7.32%
H: 1.16%
C: -7.7%
PXMD | $0.7784 -2.69% -2.76% 710K
|
Health Technology
|
| O: 46.45%
H: 16.3%
C: -6.17%
GTHX | $4.16 -2.8% -2.88% 690K
|
Health Technology
|
| O: -23.86%
H: 2.92%
C: -0.61%
topline therapy results study
Taysha Gene Therapies to Host Conference Call to Discuss Astellas Pharma’s Strategic Investment to Support the Development of Taysha’s AAV-based Gene Therapy Programs
Published: 2022-10-24 (Crawled : 00:00) - globenewswire.com
TSHA | $2.4 -2.04% -2.08% 2M
|
Health Technology
|
| O: 45.7%
H: 36.36%
C: 35.45%
conference therapy
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.